18578966. PREFUSION-STABILIZED CHIMERIC HMPV-RSV F PROTEINS simplified abstract (Board of Regents, The University of Texas System)

From WikiPatents
Revision as of 06:43, 1 October 2024 by Wikipatents (talk | contribs) (Creating a new page)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

PREFUSION-STABILIZED CHIMERIC HMPV-RSV F PROTEINS

Organization Name

Board of Regents, The University of Texas System

Inventor(s)

Jason Mclellan of Austin TX (US)

Ching-Lin Hsieh of Austin TX (US)

PREFUSION-STABILIZED CHIMERIC HMPV-RSV F PROTEINS - A simplified explanation of the abstract

This abstract first appeared for US patent application 18578966 titled 'PREFUSION-STABILIZED CHIMERIC HMPV-RSV F PROTEINS

    • Simplified Explanation:**

The patent application discusses chimeric hMPV/RSV F proteins that show improved stability and expression. These proteins can be used in diagnostics, screening platforms, and vaccine compositions.

    • Key Features and Innovation:**
  • Chimeric hMPV/RSV F proteins with enhanced stability and expression.
  • Potential use in diagnostics, screening platforms, and vaccines.
    • Potential Applications:**

The technology can be applied in:

  • Diagnostics for respiratory syncytial virus (RSV) and human metapneumovirus (hMPV).
  • Screening platforms for drug discovery.
  • Vaccine compositions for RSV and hMPV.
    • Problems Solved:**
  • Addressing the need for stable and highly expressed F proteins for RSV and hMPV.
  • Improving the efficacy of diagnostics and vaccines for these viruses.
    • Benefits:**
  • Enhanced stability and expression of F proteins.
  • Improved accuracy in diagnostics.
  • Potential for more effective vaccines.
    • Commercial Applications:**
  • Title: Enhanced Chimeric hMPV/RSV F Proteins for Diagnostics, Screening, and Vaccines
  • The technology can be commercialized in the pharmaceutical industry for developing diagnostic kits, screening assays, and vaccine formulations for RSV and hMPV.
    • Questions about Chimeric hMPV/RSV F Proteins:**

1. What are the specific advantages of using chimeric hMPV/RSV F proteins in diagnostics and vaccines? 2. How do these chimeric proteins compare to traditional F proteins in terms of stability and expression levels?


Original Abstract Submitted

Provided herein are chimeric hMPV/RSV F proteins. In some aspects, the chimeric hMPV/RSV F proteins exhibit enhanced conformational stability, enhanced thermostability, and/or increased expression. Methods are also provided for use of the chimeric F proteins as diagnostics, in screening platforms, and/or in vaccine compositions.